Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-21-016515)

Filing Details

Accession Number:: 0001567619-21-016515
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-08-31 17:01:19
Reporting Period:: 2021-05-28

Accepted Time:: 2021-08-31 17:01:19
Original Submission Date:: 2021-06-01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1740719	V Kathy Turner	C/O Idexx Laboratories, Inc. One Idexx Drive Westbrook ME 04092	Senior Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-28	2,000	$558.44	2,866	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	100	Indirect	by spouse

Footnotes

Amendment is being filed to correct the number of shares of Issuer common stock held.
The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.